Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma.
about
Transfusion-related acute lung injury; clinical perspectivesNegative experiences and donor return: an examination of the role of asking for something different.Platelet transfusions for patients with haematological malignancies: who needs them?Approach of using established and new laboratory tests to more comprehensively investigate noninfectious and nonhemolytic transfusion reactions--along with the experience in Japan.Possible transfusion-related acute lung injury (TRALI) in cardiac surgery patientsExperimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivoThe effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantationUse of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection.A prophylactic fresh frozen plasma transfusion leads to a possible case of transfusion-related acute lung injuryBenefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).Human neutrophil antibodies in a blood donor population: a lookback studyAcute lung injury after platelet transfusion in a patient with dengue feverThe role of neutrophils in the pathogenesis of transfusion-related acute lung injury.An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) productionIncidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients.Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcomeExperimental models of transfusion-related acute lung injury.Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.Implementation of a military-derived damage-control resuscitation strategy in a civilian trauma center decreases acute hypoxia in massively transfused patientsThe utility of clinical predictors of acute lung injury: towards prevention and earlier recognitionIdentification of specificities of antibodies against human leukocyte antigens in blood donors.The plasma fraction of stored erythrocytes augments pancreatic cancer metastasis in male versus female mice.Gender-specific transfusion affects tumor-associated neutrophil: macrophage ratios in murine pancreatic adenocarcinoma.Transfusion-related acute lung injury (TRALI): current concepts and misconceptions.Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury.Proteomic analyses of human plasma: Venus versus Mars.MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in miceRisky Bodies in the Plasma Bioeconomy: A Feminist Analysis.Transfusion-related acute lung injury: incidence and risk factors.Alternative blood products and clinical needs in transfusion medicineTransfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill.Adverse effects of plasma transfusionTransfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injuryEvaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013).Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI).Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantationImplementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donorsCryoprecipitate therapy.
P2860
Q28081342-52D284CF-BDA2-48C5-BE03-A63D34838301Q33166350-CF732924-0EDB-4F4E-9823-FE65E4BA223FQ33395509-D886B01A-D57D-41DF-B963-D35947D972EBQ33408363-031CBD6A-877B-4F26-B2A0-EBF26A36DD0DQ33564923-218DDD6D-3691-4567-BD2D-4A716B7BD494Q33697274-EBEFD325-4EE5-46B0-BC79-1B652C548A54Q33736615-78CBBB86-CFA4-4518-B973-0A465D7D8395Q33760834-485AC0BA-33F8-444C-AEF7-5CECC6341C25Q33788326-2EC5624A-078F-42B3-8CD5-F75B775C88F4Q33955808-39B15BD7-61F3-48C0-9745-41AD72EED0E5Q34038651-D5E283FE-77EA-4A0D-A6AF-2043AF489CDEQ34046149-E969C8DC-9642-49D1-BBF4-59B1BB6B33CCQ34073107-5355DEF2-BDB0-4B1D-A4E8-C997B4A871F4Q34118409-5668CD02-E01C-441C-B751-437118FBF024Q34148215-9A639B95-0222-4462-8DD8-FEDA60C624CAQ34170859-6B3E82C8-07C1-4287-A362-6DA31695374FQ34424989-11581EF7-7B95-4263-8492-B81D59CDAF78Q34434386-5AC3DC8F-004D-417E-AC19-532710DB9E4BQ34447443-C230F94F-3224-4F2E-920F-395B3A37EFF6Q34531815-61CBA0E8-9F5C-4DF8-B24E-0B9727F1E962Q34575615-C781D53A-C056-43DC-B126-A3887F14249BQ34603444-110FD88D-C592-433D-88D1-DFEDA5F27049Q34703678-6E4C8576-974C-46BF-A54D-D224BA60E36BQ35097390-096ACF40-E35E-4AC6-88DE-EC2574645F09Q35097399-35E188C5-EFBE-4B51-8A26-2E8A1CECB88AQ35100910-97A6D796-382A-4112-8C82-AAEC1D1805A4Q35231541-6A3F39E2-22DB-4F11-B4A1-DF027C36BF7FQ35605878-085894B6-C36A-4250-8C62-625FDF2AE082Q35669060-3819F597-BC6A-40E6-B03D-2B6174AA8DB7Q35742103-8D95E6A0-6B04-43B3-B69B-B2A1BB7869E7Q35777001-FD0DCC65-E888-4A0F-B83C-5F59F98CDF4AQ35915095-7AE20F97-4A5F-4543-B037-59C5C8A64F35Q35940036-253E1594-5939-44E3-A007-D2EA823EC2FBQ35972184-9431430D-DC02-4B84-A6B4-CA6185B073CAQ36049715-BB095D1A-6E08-4833-8328-50EA7BD1B638Q36058263-5AFDFFE1-05D1-404C-B89B-2B93E78504C7Q36093548-63B0DC92-71DD-4029-868A-A159BC3060AAQ36103363-D0E47651-9E43-44CC-8661-0D13643D0A02Q36160000-E6A4B45F-7BCF-47A5-A6D6-29F381059CD5Q36232259-F2E89E63-E487-4340-A75F-78D74293BDAE
P2860
Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ten years of hemovigilance rep ...... tial use of male donor plasma.
@en
Ten years of hemovigilance rep ...... tial use of male donor plasma.
@nl
type
label
Ten years of hemovigilance rep ...... tial use of male donor plasma.
@en
Ten years of hemovigilance rep ...... tial use of male donor plasma.
@nl
prefLabel
Ten years of hemovigilance rep ...... tial use of male donor plasma.
@en
Ten years of hemovigilance rep ...... tial use of male donor plasma.
@nl
P2093
P1433
P1476
Ten years of hemovigilance rep ...... tial use of male donor plasma.
@en
P2093
Catherine E Chapman
Cliff Morgan
Cristina Navarrete
Dorothy Stainsby
Edwin Massey
Elizabeth Love
Geoff Lucas
Hannah Cohen
Hilary Jones
Lorna M Williamson
P304
P356
10.1111/J.1537-2995.2008.01948.X
P577
2008-10-28T00:00:00Z